Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 875 of 6351
-
Can a new antibody calm the immune attack in CIDP?
Disease control Stopped earlyThis is a multi-center, randomized, quadruple-blind, placebo-controlled study to evaluate the efficacy and safety of batoclimab in adult participants with active CIDP. The study includes an up to 4-week Screening Period, an up to 12-week Washout Period, a 12-week Randomized Treat…
Phase 2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could flickering lights and sounds slow Alzheimer's? MIT launches home device trial
Disease control Recruiting nowAlzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. The investigator's lab found that boosting gamma waves in AD mouse models using light and sound stimulation …
Sponsor: Massachusetts Institute of Technology • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
A shot of nicorandil before stenting might keep blood flowing
Disease control Recruiting nowThe aim of this study was to determine the effect of intra-coronary administration of nicorandil on the prevention of lowering of coronary blood flow for high-risk plaque lesions defined as the high value of lipid core burden index in patients with coronary artery disease who req…
Phase 4 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New combo attack on hard-to-treat lymphoma shows promise in early trial
Disease control Recruiting nowThe purpose of this research study is to test if a combination treatment of chimeric antigen receptor (CAR) T-cell therapy, Mosunetuzumab, and Polatuzumab Vedotin will result in tumor reduction.
Phase 2 • Sponsor: Lazaros Lekakis • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug shows promise for tough head and neck cancers
Disease control CompletedThis is a multi-center, open-label Phase 2 study designed to evaluate the efficacy and safety of BA3021 as monotherapy and combination therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Phase 2 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New radiation boost shows promise for elderly glioblastoma patients
Disease control OngoingThe usual standard of care for patients over 65 diagnosed with glioblastoma ("GBM") or Grade 4 astrocytoma, IDH-mutant is a 3-week course of radiotherapy, with concurrent and adjuvant temozolomide (TMZ). This radiation dose and length of treatment are less than what would be give…
Phase 2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill could tame lupus flares in major trial
Disease control OngoingThe goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to severe symptoms. The main questions it aims to answer are: * How well cenerimod works on top of the treatment already being administer…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Real-World study shows tezepelumab helps tame severe asthma
Disease control CompletedA study involving primary data collection within real-world settings of participants who initiate treatment with tezepelumab for severe uncontrolled asthma. This study will complement evidence obtained from randomized controlled trials and provide new data focusing on the holisti…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo targets Hard-to-Treat lung cancer
Disease control OngoingThe purpose of this study is to identify the recommended Phase 2 combination dose (RP2CD\[s\]) of the amivantamab and capmatinib combination therapy in participants with non-small cell lung cancer (NSCLC) in Phase 1 (combination dose selection), and to evaluate the antitumor effe…
Phase 1/2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New cocktail of drugs takes on tough pancreatic cancer
Disease control OngoingThis is a single-center, single-arm, open-label, phase 2 clinical study, to explore the efficacy and safety of surufatinib combined with sintilimab and AG in first-line therapy of patients with locally advanced or metastatic pancreatic cancer.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 14:23 UTC
-
Drug cocktail may save tiniest Babies' hearts and lungs
Disease control Recruiting nowPatent ductus arteriosus (PDA), the most common cardiovascular complication of prematurity, is associated with higher mortality and morbidities in extremely low gestational age neonates (ELGANs, \< 27+0 weeks). Ibuprofen and acetaminophen, which act by reducing prostaglandin synt…
Phase 2 • Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Hydrogel plug could stop dangerous bleeding without surgery
Disease control OngoingTo evaluate the safety and effectiveness of Embrace Hydrogel Embolic System for the transcatheter embolization of peripheral arterial bleeds.
Sponsor: Instylla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for wheezy tots: daily pill may cut infections
Prevention OngoingThis study will assess the efficacy and safety of OM-85 compared to placebo in reducing the number of respiratory tract infections (RTIs) in children aged between 6 months and 5 years.
Phase 4 • Sponsor: OM Pharma SA • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
New hope for long COVID heart sufferers: drug combo trial launches
Disease control OngoingLong COVID or Postacute sequelae of COVID-19 infection (PASC) are increasingly recognised complications, defined by lingering symptoms, not present prior to the infection, typically persisting for more than 4 weeks. Cardiac symptoms due to post-acute inflammatory cardiac involvem…
Phase 3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for tough melanoma: experimental drug targets resistant tumors
Disease control OngoingThis study is an open-label, 2-part, Phase 2, multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination with balstilimab in participants with advanced cutaneous melanoma refractory to checkpoin…
Phase 2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy aims to save rectums from surgery
Disease control OngoingGiven the growing focus on preserving organ function and the utilization of neoadjuvant therapy, it is important to investigate and enhance the application of comprehensive neoadjuvant therapy in low rectal cancer. This approach aims to minimize or circumvent the organ dysfunctio…
Phase 2 • Sponsor: Pei-Rong Ding • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
A sharper eye on the heart: new blood test aims to spot heart attacks faster
Diagnosis CompletedThe Mindray High Sensitivity Troponin-I Measurement System is an in vitro diagnostic test for the quantitative determination of high sensitivity cardiac troponin I (hs-cTnI) in human serum or plasma. The Mindray High Sensitivity Troponin-I Measurement System is to be used as an …
Sponsor: Fred Apple • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Liver zapping may supercharge lung cancer treatment
Disease control Recruiting nowThe purpose of this study is to see whether adding liver stereotactic ablative radiotherapy/L-SABR to standard drug therapy is better than standard drug therapy alone for people with metastatic non-small cell lung cancer/NSCLC.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New valve offers hope for leaky heart condition
Disease control OngoingThe objective of this study is to evaluate the safety and performance of Cardiovalve TR system
Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Weekly shot could transform bleeding prevention for kids with hemophilia
Disease control Recruiting nowThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called marstacimab) for the potential treatment of hemophilia in pediatric patients. This study will enroll pediatric participants from ages 1 to 17 years in a sequential manner. T…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC